Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,680
+$80 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,005
of 1,040 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $104,029 across 10 Diagnostics & Research names. LH ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
130 | $35,288 | |
| 2 | ILMN |
Illumina, Inc.
|
185 | $32,528 | |
| 3 | GH |
Guardant Health, Inc.
|
101 | $15,153 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
21 | $11,055 | |
| 5 | DHR |
Danaher Corp /De/
|
18 | $3,428 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
6 | $3,008 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
6 | $1,680 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
5 | $966 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,680 | 6 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,600 | 6 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $1,505 | 6 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,722 | 6 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $787 | 3 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $698 | 3 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $1,146 | 5 | Shares | Defined | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||